Works matching IS 15307905 AND DT 2023 AND VI 23 AND IP 5/6
Results: 7
Cardiovascular Harmful Effects of Recommended Daily Doses (13 µg/kg/day), Tolerable Upper Intake Doses (0.14 mg/kg/day) and Twice the Tolerable Doses (0.28 mg/kg/day) of Copper.
- Published in:
- Cardiovascular Toxicology, 2023, v. 23, n. 5/6, p. 218, doi. 10.1007/s12012-023-09797-3
- By:
- Publication type:
- Article
Retraction Note: Ergosterol Attenuates Isoproterenol-Induced Myocardial Cardiotoxicity.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Electropharmacological Characterization of Licorice Using the Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Sheets and the Chronic Atrioventricular Block Dogs.
- Published in:
- Cardiovascular Toxicology, 2023, v. 23, n. 5/6, p. 207, doi. 10.1007/s12012-023-09795-5
- By:
- Publication type:
- Article
The Acute Effect of Trimethylamine-N-Oxide on Vascular Function, Oxidative Stress, and Inflammation in Rat Aortic Rings.
- Published in:
- Cardiovascular Toxicology, 2023, v. 23, n. 5/6, p. 198, doi. 10.1007/s12012-023-09794-6
- By:
- Publication type:
- Article
Intermittent Hypoxic Preconditioning Plays a Cardioprotective Role in Doxorubicin-Induced Cardiomyopathy.
- Published in:
- Cardiovascular Toxicology, 2023, v. 23, n. 5/6, p. 185, doi. 10.1007/s12012-023-09793-7
- By:
- Publication type:
- Article
Protective Role of Short-term Aerobic Exercise Against Zinc Oxide Nanoparticles-Induced Cardiac Oxidative Stress Via Possible Changes of Apelin, Angiotensin II/Angiotensin II Type I Signalling Pathway.
- Published in:
- Cardiovascular Toxicology, 2023, v. 23, n. 5/6, p. 177, doi. 10.1007/s12012-023-09792-8
- By:
- Publication type:
- Article
Retraction Note: Alpha-Lipoic Acid Protects Against Doxorubicin-Induced Cardiotoxicity by Regulating Pyruvate Dehydrogenase Kinase 4.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice